UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                        Date of Report: December 31, 2018

                             THE POCKET SHOT COMPANY
                         -------------------------------
                (Name of registrant as specified in its charter)

    Colorado                   333-212055                  71-0952431
   -----------                ---------------          ------------------
    State of                  Commission File            IRS Employer
  Incorporation                  Number                 Identification  No.

                            1624 N. Washington Street
                                Denver, CO 80203
                         -------------------------------
                     Address of principal executive offices

                                 (800) 560-5148
                          ----------------------------
                      Telephone number, including Area code

                               32950 Inverness Dr.
                               Evergreen, CO 80439
                         -------------------------------
           Former name or former address if changed since last report

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    40.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the  Registrant is an emerging  growth company as
defined in Rule 405 of the  Securities  Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

      Emerging Growth Company [x]

If an emerging  growth  company,  indicate by check mark if the  Registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial  accounting  standards provided pursuant to Section 13a of the
Exchange Act. [ ]


                                       1
<PAGE>

Item 2.01.  Completion of Acquisition or Disposition of Assets

     On December  31, 2018 Pure Harvest  Cannabis  Producers,  Inc.  ("PHC") was
acquired  by the  Company.  At the  time of the  acquisition,  the  Company  had
6,808,657  outstanding  shares of common  stock.  The Company  issued  8,953,008
shares of its common  stock,  as well as  warrants  to  purchase  an  additional
8,953,008  shares of the Company's  common stock to the  shareholders  of PHC in
exchange  for all of the  outstanding  shares of PHC.  PHC is now a wholly owned
subsidiary of PCKK.

     In connection with this acquisition,  the following management changes took
place on December 31, 2018:

     o    Jarrold Bachman resigned as an officer and director of the Company;

     o    David  Lamadrid  became a director of the  Company  and the  Company's
          Chief Executive Officer; and

     o    Sterling Scott became the Executive Chairman of the Company's Board of
          Directors

      Matthew Gregarek remained as a director of the Company.

      Unless otherwise indicated, all references to the Company include the
business and operations of PHC.

     As a result of the  acquisition  of PHC the  Company's  new  business  plan
involves  the  acquisition  of  licensed  medical  and  recreational   marijuana
dispensaries,  cultivation  facilities and production facilities in states which
allow publicly  traded  companies to own and operate  dispensaries,  cultivation
facilities and production facilities.  The Company plans to use a combination of
cash, shares of common or preferred stock, notes, or other financing vehicles to
complete these acquisitions.

     As an  alternative  to a standard  acquisition,  the  Company may use joint
ventures  and/or  licensing  arrangements  to provide the Company  with the same
economic benefits as would be obtained from an outright acquisition.

     The Company  will be  dedicated  to the  research  and  development  of the
highest  quality  products to support patient  wellness and healthy living.  The
Company  intends to develop  into a large  vertically  integrated  producer  and
distributor of cannabis initially  targeting states with attractive markets that
have legalized cannabis for both medicinal and adult-use.  The Company will also
enter  markets  that  are  in  various  stages  of  legalization   with  branded
hemp-derived  CBD and terpene  infused  product  lines.  In addition to products
tailored to marijuana retail  dispensaries,  the Company's line will incorporate
infused product options including beverages,  edibles,  topicals,  concentrates,
and distillates.

     The Company plans to call a special meeting of its  shareholders to approve
a 2-for-1 forward split of its common stock.

                                       2
<PAGE>


      The Company's current officers and directors are:

         Name                Age    Position
         ----                ---    --------

         David Lamadrid       47    Chief Executive Officer and a Director

         Sterling Scott       62    Executive  Chairman  of  the  Company's
                                    Board  of Directors

         Matthew Gregarek     38    Director

     David  Lamadrid  has been an officer  and  director  of the  Company  since
December 31, 2018. Mr.  Lamadrid has more than 18 years of executive  management
experience in private and public companies. Mr. Lamadrid was President and Chief
Financial Officer of Cannabis Life Sciences,  a vertically  integrated  cannabis
wholesale  producer and retailer between December 2017 and July 2018. In January
2017 Mr. Lamadrid  founded and was CEO of the Pure Harvest  Cannabis  Producers,
Inc.  Between 2012 and 2016, Mr.  Lamadrid served first as the CFO and then as a
member of the U.S. Senior  Executive  Management Team at ARRI Rental,  a leading
provider of camera,  grip and  lighting  equipment.  From 2002 until  2012,  Mr.
Lamadrid was the Chief  Financial  Officer of  CytoSorbents,  a publicly  traded
critical-care  immunotherapy  company  treating  patients with life  threatening
illnesses,  where  he  was a key  member  of  the  management  team  that  built
operations  from early start-up  through  commercialization,  setting  strategic
direction,  taking the company public,  raising over $60 million in equity,  and
securing  regulatory  marketing  approval for its medical  device.  Mr. Lamadrid
received his MBA in Management  and Finance from the New York  University  Stern
School of Business.

     Sterling  Scott has been the Executive  Chairman of the Company's  Board of
Directors  since  December  31,  2018.  Since 2014 Mr.  Scott has been a passive
investor in private  entities in addition to  providing  consulting  services to
emerging companies in the cannabis industry, including REMY Biosciences based in
Irvine, California and the Madrone Group Companies based in Ashland, Oregon. Mr.
Scott was an officer of OCG,  Inc.  between March 2018 and October 3, 2018 and a
director of OCG,  Inc.  between  March 2018 and  December  18,  2018.  From 2012
through May 2014,  Mr. Scott served as Chairman and Chief  Executive  Officer of
Woodland  Hills,  California  based  Growlife,  Inc., a  corporation  engaged in
supplying and providing  services to the cannabis  industry.  Mr. Scott received
his  Bachelor  of Arts degree in Social  Sciences  and his JD degree from DePaul
University.

     Mr. Gregarek founded Alternity Capital Management, LLC (ACM) in 2010, which
specializes in providing alternative  investments to the private sector that are
non-correlated to the typical capital markets, mainly focusing in the automobile
financial sector. He has grown ACM to $15mm in assets under management,  and has
performed  duties at ACM involving  financial  management  since 2012.  Prior to
founding ACM, Mr. Gregarek was the managing partner of Access Capital Investment
Group,  LLC,  ("ACIG")  and the manager of a privately  funded auto  acquisition
company  called  Capex  Acquisitions,  LLC,  where he  specialized  in portfolio
management, business development, and investor relations. He helped grow ACIG to
$20 million under management  before selling all of his interest in ACIG in May,
2010.  Mr.  Gregarek has been a director of the Company since July 2, 2015.  Mr.
Gregarek received a B.S. in finance from the University of Colorado.

                                       3

<PAGE>

     The following table shows the ownership,  as of December 31, 2018, of those
persons  owning  beneficially  5% or more of the Company's  common stock and the
number and  percentage  of  outstanding  shares  owned by each of the  Company's
directors  and officers and by all  officers  and  directors as a group.  Unless
otherwise indicated,  each owner has sole voting and investment power over their
shares of common stock.

                                                            % of Outstanding
      Name                                Shares Owned           Shares
      ----                                ------------      -----------------

      David Lamadrid                        1,783,600            11.3%
      Sterling Scott                        1,200,000             7.6%
      Matthew Gregarek                        250,000             1.6%

      Locke Mountain Vineyard, LLC            870,000             5.5%

      All officers and directors as a
          group (three persons)             3,233,600             20.5%


     Locke Mountain Vineyard, LLC is controlled by Jarrold Bachman.

     All of the  shareholders  in the  above  table  acquired  their  shares  in
connection with the Company's acquisition of PHC.

     In connection  with the  Company's  acquisition  of PHC the Company  issued
warrants to the former shareholders of PHC, including the persons shown below:

                              Shares issuable
                             upon the exercise    Exercise       Expiration
Name                            of warrants         Price           Date
----                         -----------------    ---------       ---------

David Lamadrid                   1,783,600          $8.00          12/31/21
Sterling Scott                   1,200,000          $8.00          12/31/21
Matthew Gregarek                   250,000          $8.00          12/31/21

Locke Mountain Vineyard, LLC       870,000          $8.00          12/31/21

Item 3.02.  Unregistered Sales of Equity Securities.

     See Item 2.01 of this report for  information  concerning  the  issuance of
shares of the Company's common stock and warrants to the shareholders of PHC

     The Company  relied upon the exemption  provided by Section  4(a)(2) of the
Securities  Act of 1933 in  connection  with issuance of the shares and warrants
described  above.  The persons  who  acquired  these  shares and  warrants  were
sophisticated  investors  and  were  provided  full  information  regarding  the
Company's  business  and  operations.  There  was  no  general  solicitation  in
connection with the offer or sale of these securities.  The persons who acquired
these  securities  acquired  them  for  their  own  accounts.  The  certificates
representing  these securities will bear a restricted legend providing that they
cannot be sold except  pursuant to an  effective  registration  statement  or an
exemption from registration.  No commission was paid to any person in connection
with the issuance or sale of these securities.

                                       4
<PAGE>

Item 5.02.  Departure of Directors or Certain Officers;  Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangements of
            Certain Officers.

      See Item 2.01 of this report.

Item 9.01.  Financial Statement and Exhibits

      The financial statements required by this item will be filed with an
amendment to this report.






                                       5
<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

January 2, 2019

                                       THE POCKET SHOT COMPANY



                                       By: /s/ David Lamadrid
                                          ---------------------------
                                          David Lamadrid
                                          Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kphmerger1-19.txt", "secsgml_size_bytes": 13249}]
{"company-data": {"conformed-name": "Pocket Shot Co", "cik": "0001351573", "assigned-sic": "2080", "irs-number": "000000000", "state-of-incorporation": "CO"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-212055", "film-number": "19512648"}, "business-address": {"street1": "32950 INVERNESS DR", "city": "EVERGREEN", "state": "CO", "zip": "80439", "phone": "303-674-2622"}, "mail-address": {"street1": "32950 INVERNESS DR", "city": "EVERGREEN", "state": "CO", "zip": "80439"}, "former-company": {"former-conformed-name": "Pocket Shot co", "date-changed": "20060131"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                        Date of Report: December 31, 2018

                             THE POCKET SHOT COMPANY
                         -------------------------------
                (Name of registrant as specified in its charter)

    Colorado                   333-212055                  71-0952431
   -----------                ---------------          ------------------
    State of                  Commission File            IRS Employer
  Incorporation                  Number                 Identification  No.

                            1624 N. Washington Street
                                Denver, CO 80203
                         -------------------------------
                     Address of principal executive offices

                                 (800) 560-5148
                          ----------------------------
                      Telephone number, including Area code

                               32950 Inverness Dr.
                               Evergreen, CO 80439
                         -------------------------------
           Former name or former address if changed since last report

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    40.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the  Registrant is an emerging  growth company as
defined in Rule 405 of the  Securities  Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

      Emerging Growth Company [x]

If an emerging  growth  company,  indicate by check mark if the  Registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial  accounting  standards provided pursuant to Section 13a of the
Exchange Act. [ ]

                                       1
Item 2.01.  Completion of Acquisition or Disposition of Assets

     On December  31, 2018 Pure Harvest  Cannabis  Producers,  Inc.  ("PHC") was
acquired  by the  Company.  At the  time of the  acquisition,  the  Company  had
6,808,657  outstanding  shares of common  stock.  The Company  issued  8,953,008
shares of its common  stock,  as well as  warrants  to  purchase  an  additional
8,953,008  shares of the Company's  common stock to the  shareholders  of PHC in
exchange  for all of the  outstanding  shares of PHC.  PHC is now a wholly owned
subsidiary of PCKK.

     In connection with this acquisition,  the following management changes took
place on December 31, 2018:

     o    Jarrold Bachman resigned as an officer and director of the Company;

     o    David  Lamadrid  became a director of the  Company  and the  Company's
          Chief Executive Officer; and

     o    Sterling Scott became the Executive Chairman of the Company's Board of
          Directors

      Matthew Gregarek remained as a director of the Company.

      Unless otherwise indicated, all references to the Company include the
business and operations of PHC.

     As a result of the  acquisition  of PHC the  Company's  new  business  plan
involves  the  acquisition  of  licensed  medical  and  recreational   marijuana
dispensaries,  cultivation  facilities and production facilities in states which
allow publicly  traded  companies to own and operate  dispensaries,  cultivation
facilities and production facilities.  The Company plans to use a combination of
cash, shares of common or preferred stock, notes, or other financing vehicles to
complete these acquisitions.

     As an  alternative  to a standard  acquisition,  the  Company may use joint
ventures  and/or  licensing  arrangements  to provide the Company  with the same
economic benefits as would be obtained from an outright acquisition.

     The Company  will be  dedicated  to the  research  and  development  of the
highest  quality  products to support patient  wellness and healthy living.  The
Company  intends to develop  into a large  vertically  integrated  producer  and
distributor of cannabis initially  targeting states with attractive markets that
have legalized cannabis for both medicinal and adult-use.  The Company will also
enter  markets  that  are  in  various  stages  of  legalization   with  branded
hemp-derived  CBD and terpene  infused  product  lines.  In addition to products
tailored to marijuana retail  dispensaries,  the Company's line will incorporate
infused product options including beverages,  edibles,  topicals,  concentrates,
and distillates.

     The Company plans to call a special meeting of its  shareholders to approve
a 2-for-1 forward split of its common stock.

                                       2
The Company's current officers and directors are:

         Name                Age    Position
         ----                ---    --------

         David Lamadrid       47    Chief Executive Officer and a Director

         Sterling Scott       62    Executive  Chairman  of  the  Company's
                                    Board  of Directors

         Matthew Gregarek     38    Director

     David  Lamadrid  has been an officer  and  director  of the  Company  since
December 31, 2018. Mr.  Lamadrid has more than 18 years of executive  management
experience in private and public companies. Mr. Lamadrid was President and Chief
Financial Officer of Cannabis Life Sciences,  a vertically  integrated  cannabis
wholesale  producer and retailer between December 2017 and July 2018. In January
2017 Mr. Lamadrid  founded and was CEO of the Pure Harvest  Cannabis  Producers,
Inc.  Between 2012 and 2016, Mr.  Lamadrid served first as the CFO and then as a
member of the U.S. Senior  Executive  Management Team at ARRI Rental,  a leading
provider of camera,  grip and  lighting  equipment.  From 2002 until  2012,  Mr.
Lamadrid was the Chief  Financial  Officer of  CytoSorbents,  a publicly  traded
critical-care  immunotherapy  company  treating  patients with life  threatening
illnesses,  where  he  was a key  member  of  the  management  team  that  built
operations  from early start-up  through  commercialization,  setting  strategic
direction,  taking the company public,  raising over $60 million in equity,  and
securing  regulatory  marketing  approval for its medical  device.  Mr. Lamadrid
received his MBA in Management  and Finance from the New York  University  Stern
School of Business.

     Sterling  Scott has been the Executive  Chairman of the Company's  Board of
Directors  since  December  31,  2018.  Since 2014 Mr.  Scott has been a passive
investor in private  entities in addition to  providing  consulting  services to
emerging companies in the cannabis industry, including REMY Biosciences based in
Irvine, California and the Madrone Group Companies based in Ashland, Oregon. Mr.
Scott was an officer of OCG,  Inc.  between March 2018 and October 3, 2018 and a
director of OCG,  Inc.  between  March 2018 and  December  18,  2018.  From 2012
through May 2014,  Mr. Scott served as Chairman and Chief  Executive  Officer of
Woodland  Hills,  California  based  Growlife,  Inc., a  corporation  engaged in
supplying and providing  services to the cannabis  industry.  Mr. Scott received
his  Bachelor  of Arts degree in Social  Sciences  and his JD degree from DePaul
University.

     Mr. Gregarek founded Alternity Capital Management, LLC (ACM) in 2010, which
specializes in providing alternative  investments to the private sector that are
non-correlated to the typical capital markets, mainly focusing in the automobile
financial sector. He has grown ACM to $15mm in assets under management,  and has
performed  duties at ACM involving  financial  management  since 2012.  Prior to
founding ACM, Mr. Gregarek was the managing partner of Access Capital Investment
Group,  LLC,  ("ACIG")  and the manager of a privately  funded auto  acquisition
company  called  Capex  Acquisitions,  LLC,  where he  specialized  in portfolio
management, business development, and investor relations. He helped grow ACIG to
$20 million under management  before selling all of his interest in ACIG in May,
2010.  Mr.  Gregarek has been a director of the Company since July 2, 2015.  Mr.
Gregarek received a B.S. in finance from the University of Colorado.

                                       3
The following table shows the ownership,  as of December 31, 2018, of those
persons  owning  beneficially  5% or more of the Company's  common stock and the
number and  percentage  of  outstanding  shares  owned by each of the  Company's
directors  and officers and by all  officers  and  directors as a group.  Unless
otherwise indicated,  each owner has sole voting and investment power over their
shares of common stock.

                                                            % of Outstanding
      Name                                Shares Owned           Shares
      ----                                ------------      -----------------

      David Lamadrid                        1,783,600            11.3%
      Sterling Scott                        1,200,000             7.6%
      Matthew Gregarek                        250,000             1.6%

      Locke Mountain Vineyard, LLC            870,000             5.5%

      All officers and directors as a
          group (three persons)             3,233,600             20.5%

     Locke Mountain Vineyard, LLC is controlled by Jarrold Bachman.

     All of the  shareholders  in the  above  table  acquired  their  shares  in
connection with the Company's acquisition of PHC.

     In connection  with the  Company's  acquisition  of PHC the Company  issued
warrants to the former shareholders of PHC, including the persons shown below:

                              Shares issuable
                             upon the exercise    Exercise       Expiration
Name                            of warrants         Price           Date
----                         -----------------    ---------       ---------

David Lamadrid                   1,783,600          $8.00          12/31/21
Sterling Scott                   1,200,000          $8.00          12/31/21
Matthew Gregarek                   250,000          $8.00          12/31/21

Locke Mountain Vineyard, LLC       870,000          $8.00          12/31/21

Item 3.02.  Unregistered Sales of Equity Securities.

     See Item 2.01 of this report for  information  concerning  the  issuance of
shares of the Company's common stock and warrants to the shareholders of PHC

     The Company  relied upon the exemption  provided by Section  4(a)(2) of the
Securities  Act of 1933 in  connection  with issuance of the shares and warrants
described  above.  The persons  who  acquired  these  shares and  warrants  were
sophisticated  investors  and  were  provided  full  information  regarding  the
Company's  business  and  operations.  There  was  no  general  solicitation  in
connection with the offer or sale of these securities.  The persons who acquired
these  securities  acquired  them  for  their  own  accounts.  The  certificates
representing  these securities will bear a restricted legend providing that they
cannot be sold except  pursuant to an  effective  registration  statement  or an
exemption from registration.  No commission was paid to any person in connection
with the issuance or sale of these securities.

                                       4
Item 5.02.  Departure of Directors or Certain Officers;  Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangements of
            Certain Officers.

      See Item 2.01 of this report.

Item 9.01.  Financial Statement and Exhibits

      The financial statements required by this item will be filed with an
amendment to this report.

                                       5
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

January 2, 2019

                                       THE POCKET SHOT COMPANY

                                       By: /s/ David Lamadrid
                                          ---------------------------
                                          David Lamadrid
                                          Chief Executive Officer